Implantable Cardioverter‐Defibrillators in Patients with Chagas Heart Disease: Misperceptions, Many Questions and the Urgent Need for a Randomized Clinical Trial

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cardiovascular Electrophysiology

• Publication date

  2007-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1540-8167.2007.01011.xPMID 17971129
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Systematic Review: Implantable Cardioverter Defibrillators for Adults with Left Ventricular Systolic Dysfunction

  2007cited by this paper
• Acompanhamento clínico de pacientes portadores de cardioversor-desfibrilador implantável

  2007cited by this paper
• Clinical follow-up of patients with implantable cardioverter-defibrillator.

  2007cited by this paper
• Predictors of All‐Cause Mortality for Patients with Chronic Chagas' Heart Disease Receiving Implantable Cardioverter Defibrillator Therapy

  2007cited by this paper
• Development and validation of a risk score for predicting death in Chagas' heart disease.

  2006cited by this paper
• Automatic Implantable Cardioverter‐Defibrillators in Chagas' Heart Disease Patients with Malignant Ventricular Arrhythmias

  2006cited by this paper
• A Latin American Registry of Implantable Cardioverter Defibrillators: The ICD‐LABOR Study

  2005cited by this paper
• Clinical Usefulness of Electrophysiologic Testing in Patients with Ventricular Tachycardia and Chronic Chagasic Cardiomyopathy Treated with Amiodarone or Sotalol

  2003cited by this paper
• Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.

  2003cited by this paper
• The impact of syncope during clinical presentation of sustained ventricular tachycardia on total and cardiac mortality in patients with chronic Chagasic heart disease.

  2001cited by this paper
• Sudden death in Chagas' disease.

  2001cited by this paper
• Probability of Occurrence of Life‐Threatening Ventricular Arrhythmias in Chagas' Disease versus Non‐Chagas' Disease

  2000cited by this paper
• Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.

  2000cited by this paper
• Chagas' Heart Disease

  2000cited by this paper
• Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators.

  1999cited by this paper
• Time to First Shock in Implantable Cardioverter Defibrillator (ICD) Patients with Chagas Cardiomyopathy

  1999cited by this paper
• Left ventricular function after repeated episodes of ventricular fibrillation and defibrillation assessed by transoesophageal echocardiography.

  1997cited by this paper
• Implantable Cardioverter Defibrillators in Patients with Chagas' Disease: Are They Different from Patients with Coronary Disease?

  1997cited by this paper
• [Empiric therapy with amiodarone in patients with chronic Chagas cardiomyopathy and sustained ventricular tachycardia].

  1990cited by this paper

• Consenso de Prevención Primaria y Secundaria de Muerte Súbita Sociedad Argentina de Cardiología - Sociedad Uruguaya de Cardiología (con la colaboración del CONAREC)

  2025cites this paper
• Evaluation of patients with implantable cardioverter‐defibrillator in a Latin American tertiary center

  2024cites this paper
• Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com Cardiomiopatia da Doença de Chagas – 2023

  2023cites this paper
• Systematic Review and Meta-Analysis of Clinical Outcome After Implantable Cardioverter-Defibrillator Therapy in Patients With Chagas Heart Disease.

  2019cites this paper
• Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management A Scientific Statement From the American Heart Association

  2018cites this paper
• Chapter 5 Utility of Cardiac Implantable Electronic Devices in Patients with Chagas Disease and Systolic Heart Failure

  2018cites this paper
• Congenital Chagas Disease in the United States: Cost Savings through Maternal Screening

  2018cites this paper
• Long‐term follow‐up of Chagas heart disease patients receiving an implantable cardioverter‐defibrillator for secondary prevention

  2018cites this paper
• Implantable cardioverter-defibrillator in Chagas heart disease: A systematic review and meta-analysis of observational studies.

  2018cites this paper
• Utility of Cardiac Implantable Electronic Devices in Patients with Chagas Disease and Systolic Heart Failure

  2017cites this paper
• Impact of the Use of Benznidazole Followed by Antioxidant Supplementation in the Prevalence of Ventricular Arrhythmias in Patients With Chronic Chagas Disease: Pilot Study

  2016cites this paper
• Chagas Disease: A Neglected Disease

  2015cites this paper
• Arrhythmias in chagasic cardiomyopathy.

  2015cites this paper
• Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe

  2015cites this paper
• Neglected Tropical Diseases - Latin America and the Caribbean

  2015cites this paper
• Epicardial Ablation for Ventricular Tachycardia in Chronic Chagas Heart Disease

  2014cites this paper
• Catheter ablation to treat sustained ventricular tachycardia in patients with chagas cardiomyopathy and implantable cardioverter-defibrillator.

  2014cites this paper
• Implantable cardioverter-defibrillator efficacy in Chagas disease patients depends not only on the device performance: optimizing the adjunct therapy is essential.

  2014cites this paper
• Special Ablation Approaches: Epicardial, Other

  2013cites this paper
• CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy Study: rationale and design of a randomized clinical trial.

  2013cites this paper
• Cardiac Magnetic Resonance Imaging for Sudden Cardiac Death. Much More Than Another Method to Measure LVEF

  2013influential citation
• Clinical problem-solving. A patient with syncope.

  2013cites this paper
• Efficacy and safety of implantable cardioverter-defibrillators in patients with Chagas disease.

  2013cites this paper
• Another disappointing result with implantable cardioverter-defibrillator therapy in patients with Chagas disease.

  2013cites this paper
• Consenso de prevención primaria y secundaria de muerte súbita Sociedad Argentina de Cardiología. Sociedad Uruguaya de Cardiología. (Con colaboración del Consejo Argentino de Residentes de Cardiología)

  2012cites this paper
• The Emerging Role of Epicardial Ablation.

  2012cites this paper
• From the Editor

  2012cites this paper
• Consensus Statement on Primary and Secondary Prevention of Sudden Death. Argentine Society of Cardiology - Uruguayan Society of Cardiology (developed in collaboration with the CONAREC)

  2012cites this paper
• Consensus Statement on Primary and Secondary Prevention of Sudden Death. Argentine Society of Cardiology-Uruguayan Society of Cardiology (with the collaboration of the CONAREC)

  2012cites this paper
• Predictors of Mortality in Patients with Chagas’ Cardiomyopathy and Ventricular Tachycardia Not Treated with Implantable Cardioverter‐Defibrillators

  2011cites this paper
• Clinical Phases and Forms of Chagas Disease

  2010cites this paper
• Evolução pós implante de cardiodesfibrilador implantavel em pacientes chagásicos e não-chagásicos: estudo comparativo

  2010cites this paper
• Cost-effectiveness of implantable cardioverter-defibrillators in Brazil: primary prevention analysis in the public sector.

  2010cites this paper
• Chagas disease.

  2010cites this paper
• Sustitución valvular en un paciente con enfermedad de chagas. consideraciones anestésicas

  2009cites this paper
• Epicardial Ablation of Ventricular Tachycardia in Chagas Heart Disease.

  2009cites this paper
• [Valve replacement in a man with Chagas disease: anesthetic considerations].

  2009cites this paper
• Flussi migratori e nuove patologie di importazione: la cardiomiopatia chagasica cronica

  2009cites this paper
• [Migration flow and imported diseases: chronic chagasic cardiomyopathy].

  2009cites this paper
• Re: Predictors of all-cause mortality for patients with chronic Chagas' heart disease receiving implantable cardioverter defibrillator therapy.

  2008cites this paper
• Prognostic Value of Signal‐Averaged Electrocardiogram in Chagas Disease

  2008cites this paper
• To the Editor:

  2008cites this paper
• Challenges and opportunities for primary, secondary, and tertiary prevention of Chagas’ disease

  2008cites this paper
• Chagas cardiomyopathy and implantable cardioverter defibrillator implantation: similarities and differences with dilated cardiomyopathy.

  2008cites this paper
• AHA SCIENTIFIC STATEMENT Chagas Cardiomyopathy: An Update of Current Clinical Knowledge and Management A Scientific Statement From the American Heart Association

  year unknowncites this paper